Ronald Merriman, Director at HAEMONETICS CORP (HAE), sold 34,942 shares at $40.31 ($1.4M) on 2017-05-22, disclosed to the SEC on 2017-05-24.
Open-market sale of $1.4M HAE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.31 | 7,118 | $287K | 20.4% |
| 2 | $40.31 | 7,118 | $287K | 20.4% |
| 3 | $40.34 | 10,353 | $418K | 29.6% |
| 4 | $40.34 | 10,353 | $418K | 29.6% |
| Total | $40.33 avg | 34,942 | $1.4M | 100% |
| Filing → |
| O | SELL | 2021-06-15 | $280K | — | Filing → |
| NVT | SELL | 2020-11-05 | $80K | — | Filing → |
| AYR | SELL | 2019-05-29 | $201K | — | Filing → |